3-43561311-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_018075.5(ANO10):​c.1385G>A​(p.Arg462Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.625 in 1,613,842 control chromosomes in the GnomAD database, including 319,572 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.60 ( 27946 hom., cov: 32)
Exomes 𝑓: 0.63 ( 291626 hom. )

Consequence

ANO10
NM_018075.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.106

Publications

38 publications found
Variant links:
Genes affected
ANO10 (HGNC:25519): (anoctamin 10) The transmembrane protein encoded by this gene belongs to the anoctamin family of calcium-activated chloride channels, also known as the transmembrane 16 family. The encoded protein contains eight transmembrane domains with cytosolic N- and C-termini. Defects in this gene may cause autosomal recessive spinocerebellar ataxia-10. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ANO10 Gene-Disease associations (from GenCC):
  • autosomal recessive spinocerebellar ataxia 10
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.683522E-7).
BP6
Variant 3-43561311-C-T is Benign according to our data. Variant chr3-43561311-C-T is described in ClinVar as Benign. ClinVar VariationId is 128387.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.869 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANO10NM_018075.5 linkc.1385G>A p.Arg462Gln missense_variant Exon 9 of 13 ENST00000292246.8 NP_060545.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANO10ENST00000292246.8 linkc.1385G>A p.Arg462Gln missense_variant Exon 9 of 13 1 NM_018075.5 ENSP00000292246.3

Frequencies

GnomAD3 genomes
AF:
0.598
AC:
90911
AN:
151942
Hom.:
27926
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.500
Gnomad AMI
AF:
0.589
Gnomad AMR
AF:
0.684
Gnomad ASJ
AF:
0.525
Gnomad EAS
AF:
0.890
Gnomad SAS
AF:
0.727
Gnomad FIN
AF:
0.642
Gnomad MID
AF:
0.576
Gnomad NFE
AF:
0.605
Gnomad OTH
AF:
0.600
GnomAD2 exomes
AF:
0.658
AC:
165338
AN:
251442
AF XY:
0.655
show subpopulations
Gnomad AFR exome
AF:
0.496
Gnomad AMR exome
AF:
0.794
Gnomad ASJ exome
AF:
0.507
Gnomad EAS exome
AF:
0.884
Gnomad FIN exome
AF:
0.635
Gnomad NFE exome
AF:
0.606
Gnomad OTH exome
AF:
0.611
GnomAD4 exome
AF:
0.628
AC:
918204
AN:
1461782
Hom.:
291626
Cov.:
54
AF XY:
0.629
AC XY:
457574
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.495
AC:
16560
AN:
33478
American (AMR)
AF:
0.778
AC:
34796
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.516
AC:
13479
AN:
26134
East Asian (EAS)
AF:
0.897
AC:
35583
AN:
39684
South Asian (SAS)
AF:
0.714
AC:
61580
AN:
86258
European-Finnish (FIN)
AF:
0.638
AC:
34079
AN:
53418
Middle Eastern (MID)
AF:
0.536
AC:
3089
AN:
5768
European-Non Finnish (NFE)
AF:
0.613
AC:
681652
AN:
1111928
Other (OTH)
AF:
0.619
AC:
37386
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
19789
39578
59368
79157
98946
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18536
37072
55608
74144
92680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.598
AC:
90984
AN:
152060
Hom.:
27946
Cov.:
32
AF XY:
0.606
AC XY:
45085
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.500
AC:
20706
AN:
41446
American (AMR)
AF:
0.684
AC:
10449
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.525
AC:
1821
AN:
3470
East Asian (EAS)
AF:
0.890
AC:
4611
AN:
5180
South Asian (SAS)
AF:
0.727
AC:
3512
AN:
4828
European-Finnish (FIN)
AF:
0.642
AC:
6779
AN:
10560
Middle Eastern (MID)
AF:
0.575
AC:
169
AN:
294
European-Non Finnish (NFE)
AF:
0.605
AC:
41134
AN:
67994
Other (OTH)
AF:
0.600
AC:
1269
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1834
3668
5502
7336
9170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
776
1552
2328
3104
3880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.600
Hom.:
94930
Bravo
AF:
0.595
TwinsUK
AF:
0.609
AC:
2258
ALSPAC
AF:
0.611
AC:
2356
ESP6500AA
AF:
0.498
AC:
2193
ESP6500EA
AF:
0.587
AC:
5050
ExAC
AF:
0.650
AC:
78972
Asia WGS
AF:
0.783
AC:
2722
AN:
3478
EpiCase
AF:
0.596
EpiControl
AF:
0.593

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Autosomal recessive spinocerebellar ataxia 10 Benign:4
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:4
Sep 25, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 18, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
7.0
DANN
Benign
0.91
DEOGEN2
Benign
0.051
T;.;.;.;.
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0057
N
LIST_S2
Benign
0.84
T;T;T;T;T
MetaRNN
Benign
6.7e-7
T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.3
L;.;.;L;.
PhyloP100
-0.11
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-1.1
N;N;N;N;N
REVEL
Benign
0.089
Sift
Benign
0.24
T;T;T;T;T
Sift4G
Benign
0.32
T;T;T;T;T
Polyphen
0.0010
B;P;B;.;B
Vest4
0.015
MPC
0.11
ClinPred
0.0036
T
GERP RS
-5.4
Varity_R
0.088
gMVP
0.081
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3772165; hg19: chr3-43602803; COSMIC: COSV107345359; COSMIC: COSV107345359; API